Advanced amplicon sequencing systems and kits for target-specific microbiome analysis
The Internal Transcribed Spacer (ITS) region of the nuclear ribosomal RNA (rRNA) cistron has emerged as the universal barcode for fungal identification. In mycobiome and microbial ecology research, amplicon sequencing targeting the ITS region provides unparalleled taxonomic resolution compared to other ribosomal markers. While 16S rRNA sequencing remains the gold standard for profiling bacterial communities, the structural diversity of fungi requires a highly variable genomic region to differentiate closely related species. This technical briefing details the biology, methodology, industrial applications, and future trends of ITS rRNA amplicon sequencing.
The ITS region contains two highly variable segments: ITS1 (located between the 18S and 5.8S rRNA genes) and ITS2 (located between the 5.8S and 28S rRNA genes). Because these spacers are spliced out during ribosomal RNA maturation, they accumulate mutations at a faster rate than the flanking functional rRNA genes. This evolutionary variability makes the ITS region ideal for distinguishing fungal taxa at the species, and sometimes even strain, level.
The eukaryotic ribosomal cistron consists of the 18S, 5.8S, and 28S genes, separated by the ITS1 and ITS2 spacers. Understanding this structure is crucial for designing amplicon sequencing assays. Depending on the research goals, investigators typically target the ITS1 region, the ITS2 region, or the full-length ITS sequence (ITS1-5.8S-ITS2).
Both ITS sub-regions have distinct advantages. Historically, ITS1 has been favored for studies targeting specific groups of fungi, such as Basidiomycetes, while ITS2 is often preferred for broad-spectrum fungal profiling because it exhibits less length variation and is less prone to PCR bias. In short-read sequencing platforms (like Illumina NovaSeq), researchers must choose one of these sub-regions because the entire ITS operon (~600 to 800 base pairs) exceeds the read-length limits of standard Next-Generation Sequencing (NGS) chemistry. However, with the advent of third-generation long-read sequencing (such as PacBio Sequel II and Oxford Nanopore PromethION), full-length ITS amplicon sequencing has become highly accessible, eliminating the need to choose between ITS1 and ITS2 and providing complete taxonomic profiles.
Selecting appropriate primer pairs is a critical factor in determining the success of an amplicon study. Classic primers such as ITS1-F, ITS2, ITS3, and ITS4 have been widely used, but they can show bias toward certain fungal phyla (e.g., Ascomycota vs. Basidiomycota). Modern assays employ degenerate primers or optimized primer cocktails to minimize taxonomic bias and ensure representative amplification of the entire fungal community within complex environmental samples.
A standard ITS amplicon sequencing project involves several key stages, each requiring strict quality control to avoid contamination and ensure reproducible data:
ITS rRNA amplicon sequencing has transitioned from academic ecological surveys to vital industrial applications. Understanding fungal communities is critical across multiple commercial sectors:
Fungi play a vital role in soil ecosystems as decomposers, pathogens, and mutualists (e.g., Arbuscular Mycorrhizal Fungi). ITS sequencing allows agro-tech companies to assess soil health, monitor the efficacy of bio-fertilizers, and detect crop pathogens (such as Fusarium or Botrytis) before symptoms appear in the field.
From cheese ripening and sourdough production to brewing and wine fermentation, yeasts and molds drive the food industry. ITS profiling ensures batch-to-batch consistency, monitors starter culture health, and detects spoilage organisms early in production pipelines.
The human mycobiome, though less abundant than the bacteriome, plays a critical role in mucosal immunity and systemic health. ITS sequencing is used in drug development, clinical diagnostics for opportunistic fungal infections (e.g., Candida, Aspergillus), and the study of gut-brain axis interactions.
The field of fungal amplicon sequencing is evolving rapidly, driven by technological breakthroughs and computational innovations. The primary trend is the shift from short-read sub-region sequencing to full-length ITS sequencing. By capturing the complete ITS1-5.8S-ITS2 region, researchers can achieve species-level and even strain-level resolution, resolving ambiguities that have historically limited short-read studies.
Furthermore, integrating ITS amplicon data with other multi-omics approaches—such as metagenomics, metatranscriptomics, and spatial transcriptomics (using platforms like BMKMANU S3000)—enables researchers to not only identify "who is there" but also "what they are doing" in spatial context. Artificial intelligence and machine learning models are also being trained on ITS profile datasets to predict soil productivity, crop yields, and disease outbreaks in real time.
Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics. Backed by more than 60 national invention patents and 200+ software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.
PacBio platforms: Sequel II, Sequel, RSII
Nanopore platforms: PromethION P48, GridION X5, MinION
10X Genomics: 10X ChromiumX, 10X Chromium Controller
Illumina platforms: NovaSeq
BGI-sequencing platforms: DNBSEQ-G400, DNBSEQ-T7
Bionano Irys system
Waters XEVO G2-XS QTOF
QTRAP 6500+
Advanced biomolecular laboratory instruments. Standard labs for sample extraction, library construction, clean rooms, and sequencing labs. Standard procedures from sample extraction to sequencing under strict SOPs.
Self-developed BMKCloud platform with CPUs featuring 41,104 memory and 3 PB total storage. 4,260 computing cores with peak computing power over 121,708.8 Gflop per second.
Biomarker technologies (BMKGENE) and PerkinElmer have jointly built a fully automated experimental production line, called Brilliant Lab 1000 (BL1000), which is applied to the high-throughput NGS library construction service. BMKGENE strives to greatly improve the entire line of sequencing products in terms of product types, production line throughput, delivery quality, and cycle time, to provide customers with better sequencing services.









Global standards of quality management and intellectual property
Explore our full list of genomic research kits, sequencing services, and bioinformatic solutions